FIELD: medicine.
SUBSTANCE: method involves studying nuclear Ki-67 or P-63 marker expression localization in epidermis and derma layers. Marker being basally localized, keratoacanthoma is to be diagnosed. Marker being diffusely localized, squamous cell skin carcinoma is to be diagnosed.
EFFECT: high accuracy of diagnosis.
4 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSIS OF RED LICHEN PLANUS AND LYCEOPLACY OF THE ORAL MUCOSA | 2017 |
|
RU2651050C1 |
| METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
| METHOD FOR MODELING BASALIOMAS IN EXPERIMENTAL ANIMALS (RATS) | 2004 |
|
RU2270482C2 |
| METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ACTINIC KERATOSIS AND SQUAMOUS CELL CARCINOMA OF SKIN | 2019 |
|
RU2703464C1 |
| METHOD OF DETERMINATION OF RADIATION SENSITIVITY OF TUMOUR OF MOUTH MUCOSA | 2008 |
|
RU2387472C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULAR FORMATIONS OF THE THYROID GLAND | 2021 |
|
RU2783304C1 |
| METHOD OF SUPERFICIAL SKIN BASALIOMA THERAPY SELECTION | 2007 |
|
RU2327168C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTIC OF HIGH-GRADE DIFFERENTIATED ADENOCARCINOMAS AND ADENOMAS OF COLON | 2015 |
|
RU2599101C1 |
| METHOD OF SELECTING TACTICS OF TREATING ACTINIC KERATOSIS | 2012 |
|
RU2495628C1 |
